ABBVIE LTD ABPI DISCLOSURE REQUIREMENTS ON FINANCIAL SUPPORT FOR PATIENT ORGANISATIONS FOR FINANCIAL YEAR 2016

Size: px
Start display at page:

Download "ABBVIE LTD ABPI DISCLOSURE REQUIREMENTS ON FINANCIAL SUPPORT FOR PATIENT ORGANISATIONS FOR FINANCIAL YEAR 2016"

Transcription

1 ABBVIE LTD ABPI DISCLOSURE REQUIREMENTS ON FINANCIAL SUPPORT FOR PATIENT ORGANISATIONS FOR FINANCIAL YEAR 2016 Provided To Patient Organisations (2016 ABPI Clauses 27.7& 27.8) Addaction 35, Event support Funding of hepatitis C pilot Addaction 10, Event support Sponsorship of hepatitis C conference Arthritis Care 5, Organisation support Core funding Arthritis Care N Ireland Event support Sponsorship of annual lecture Arthritis & Musculoskeletal Alliance (ARMA) 5, Organisation support Core funding Arthur's Place 10, Organisation support Core funding

2 Provided To Patient BackCare 2, Organisation support Core funding Birdshot Uveitis Society 10, Organisation support Core funding BLISS 20, Organisation support Core funding BLISS 3, Disease education Sponsorship of 'Common Winter Illnesses' booklet Bloodwise Contracted services by a patient organisation Fee to participate in advisory board meeting British Liver Trust 1, Organisation support Sponsorship to attend a conference British Liver Trust 10, Event support Sponsorship of 'Liver Disease Clinical Priority Programme' Children with Crohn's and Colitis (CICRA) Contracted services by a patient organisation Fee for participation in steering group meeting CLL Association 5, Organisation support Core funding CLL Association Contracted services by a patient organisation Speaker fee CLL Association Contracted services by a patient organisation Fee to participate in advisory board meeting Crohn's & Colitis UK (CCUK) 20, Organisation support Core funding Crohn's & Colitis UK (CCUK) Contracted services by a patient organisation Fee for participation in steering group meeting Crohn's & Colitis UK (CCUK) 15, Organisation support Intern sponsorship Crohn's & Colitis UK (CCUK) 3, Event support Sponsorship of training workshop

3 Provided To Patient Cure Parkinson's Trust 1, Contracted services by a patient organisation Fee for participation in steering group meeting Cure Parkinson's Trust 8, Disease education Sponsorship of 'Patient Tips & Tricks' filming GMFA (the gay men's health charity) 11, Organisation support Sponsorship of a conference Hepatitis C Trust 65, Event support Funding of hepatitis C pilot Hepatitis C Trust 5, Event support Funding for print costs relating to hepatitis C pilot Hepatitis C Trust 43, Event support Funding for parliamentary work programme Hepatitis C Trust 30, Event support Funding for HCV Action work programme Hepatitis C Trust Contracted services by a patient organisation Speaker fee Hepatitis C Trust Contracted services by a patient organisation Speaker fee Hepatitis C Trust 24, Contracted services by a patient organisation Fee to provide part-time helpline worker for patient support programme HS Trust 5, Organisation support Core funding HS Trust Contracted services by a patient organisation Speaker fee HS Trust Contracted services by a patient organisation Fee to review 'Champions for Change' materials HS Trust 20, Organisation support Sponsorship for strategic planning HS Trust Contracted services by a patient organisation Fee for involvement in 'HS Network for Change' programme

4 Provided To Patient Leukaemia CARE 5, Organisation support Core funding Leukaemia CARE Contracted services by a patient organisation Fee to participate in advisory board meeting Liver4Life 30, Event support Sponsorship of 'Optimising Hep C ' initiative Liver4Life 10, Organisation support Funding for mobile fibroscan unit Lymphoma Association Contracted services by a patient organisation Fee to participate in advisory board meeting NAM Publications 8, Organisation support Sponsorship of infohep.org National AIDS Trust (NAT) 15, Event support Funding for policy work programme National Ankylosing Spondylitis Society (NASS) Contracted services by a patient organisation Fee for participation in steering group meeting National Ankylosing Spondylitis Society (NASS) 30, Event support Back Pain Plus sponsorship National Ankylosing Spondylitis Society (NASS) 25, Organisation support Core funding National Ankylosing Spondylitis Society (NASS) Contracted services by a patient organisation Speaker fee National Ankylosing Spondylitis Society (NASS) 20, Disease education Sponsorship of patient survey National Childbirth Trust (NCT) 9, Event support Funding for training module National Rheumatoid Arthritis Society (NRAS) Contracted services by a patient organisation Fee for participation in steering group meeting National Rheumatoid Arthritis Society (NRAS) 20, Organisation support Core funding

5 Provided To Patient National Rheumatoid Arthritis Society (NRAS) 20, Disease education Funding for quarterly magazine distribution National Rheumatoid Arthritis Society (NRAS) 2, Contracted services by a patient organisation Fee for involvement in social care research project NET Patient Foundation Contracted services by a patient organisation Fee for participation in steering group meeting Neurological Alliance 10, Event support Funding for Industry Reference Group projects Patients Association 10, Organisation support Core funding Psoriasis Association 4, Organisation support Core funding Psoriasis Association 4, Organisation support Core funding Tamba 10, Disease education Sponsorship of parenting webinars and information booklet Waverley Care Contracted services by a patient organisation Fee to attend meeting Waverley Care Contracted services by a patient organisation Speaker fee Waverley Care 10, Event support Funding for SVQ student Waverley Care 25, Event support Sponsorship of hepatitis C pilot Event support Disease education Organisation support Contracted services by a patient organisation An event or programme conducted by the patient organisation, which is sponsored by AbbVie, whether in whole or in part An educational programme directed at patients, caregivers and disease awareness programmes, which is sponsored by AbbVie, whether in whole or in part Funding for infrastructure or general programme If a patient organisation is engaged to provide a service to AbbVie AXCOR MARCH 2017

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable)

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Support to patient organisations 2014: (SPONSORSHIP) *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb

More information

Grants, Donations and Payments PATIENT ORGANISATIONS

Grants, Donations and Payments PATIENT ORGANISATIONS Z Grants, Donations and Payments 2013 - PATIENT ORGANISATIONS Name of Beneficiary Organization Program/Project Description Support Type Country Currency Amount Arthritis and Musculoskeletal Alliance (ARMA)

More information

Program/Project Description. MSD paid Arthritis and Musculoskeletal Alliance for annual Corporate Membership

Program/Project Description. MSD paid Arthritis and Musculoskeletal Alliance for annual Corporate Membership Z Grants, Donations and s 2013 - PATIENT ORGANISATIONS United Kingdom Name of Beneficiary Organization Arthritis and Musculoskeletal Alliance (ARMA) Program/Project Description MSD paid Arthritis and Musculoskeletal

More information

Support to Patient Organisations 2016

Support to Patient Organisations 2016 Support to Patient Organisations 2016 of Preparation March 2017 Country Disease Area Patient Advocacy Group Name Type of Support Description of support Cancer Campaigning Group (A coalition of a number

More information

DECEMBER 2012 PAYMENTS

DECEMBER 2012 PAYMENTS In order to align with the financial reporting periods of the majority of organisations, from this year we are disclosing payments by calender year, rather than by our financial reporting year (which runs

More information

Pfizer s 2017 patient organisation disclosure report

Pfizer s 2017 patient organisation disclosure report Executive summary Pfizer s 2017 patient organisation disclosure report Pfizer is committed to working transparently with patient organisations. For more information about how and why Pfizer works with

More information

UCB SUPPORT OF PATIENT ORGANISATIONS 2015 UK

UCB SUPPORT OF PATIENT ORGANISATIONS 2015 UK UCB SUPPORT OF PATIENT ORGANISATIONS 2015 Full Name of Patient Organisation Full Address of Patient Organisation Age Cymru Ty John Pathy, 13-14 Neptune Court, Vanguard Way, Cardiff, CF24 5PJ All Wales

More information

During 2012, Pfizer supported Age Concern with the following:

During 2012, Pfizer supported Age Concern with the following: Action on Pain Action on Pain provides advice and support to people living with pain and strives to raise the profile of pain among politicians, the NHS and healthcare professionals. During 2012, Pfizer

More information

The next steps

The next steps Greater Manchester Hepatitis C Strategy The next steps 2010-2013 Endorsed by GM Director of Public Health group January 2011 Hepatitis Greater Manchester Hepatitis C Strategy 1. Introduction The Greater

More information

Our vision is for a Scotland where people who are disabled or living with long term conditions and unpaid carers have a strong voice and enjoy their

Our vision is for a Scotland where people who are disabled or living with long term conditions and unpaid carers have a strong voice and enjoy their Our vision is for a Scotland where people who are disabled or living with long term conditions and unpaid carers have a strong voice and enjoy their right to live well. The Health and Social Care Alliance

More information

the patients perspective and role of epags

the patients perspective and role of epags Patients Registry in ERNs: the patients perspective and role of epags 5th International Summer School Rare Disease & Orphan Drug Registries VirginieBros-Facer, Research Infrastructure Project Manager 18

More information

Total Payment for sponsored attendances by Healthcare Professionals: 182,677 ( 153,923 in 2013)

Total Payment for sponsored attendances by Healthcare Professionals: 182,677 ( 153,923 in 2013) Gilead Sciences Ltd. 280 High Holborn London WC1V 7EE 31st March 2015 Relationships with Healthcare Professionals in the United Kingdom Gilead Sciences makes payments to Healthcare Professionals for consultancy

More information

Living with Leukaemia Leukaemia Care Patient Experience Survey (2016)

Living with Leukaemia Leukaemia Care Patient Experience Survey (2016) Living with Leukaemia Leukaemia Care Patient Experience Survey (2016) Zack Pemberton-Whiteley CML Horizons - Warsaw 5 th May 2018 Campaigns and Advocacy Director, Leukaemia Care (UK) CML Advocates Network

More information

MRCG Strategic Document

MRCG Strategic Document MRCG Strategic Document 2015-2016 The Medical Research Charities Group (MRCG) is an umbrella group of medical research and patient support charities that seeks to generate dynamic medical research in Ireland,

More information

Dr Tracey Kain. Associate Professor Ed Gane

Dr Tracey Kain. Associate Professor Ed Gane Associate Professor Ed Gane New Zealand Liver Transplant Unit Auckland Dr Tracey Kain Consultant Rheumatologist Grace Orthopaedic Centre Tauranga Hospital Tauranga 7:00-7:55 Abbvie Breakfast Session 1.

More information

NIHR Leeds Clinical Research Facility Patient and Public Involvement Strategy

NIHR Leeds Clinical Research Facility Patient and Public Involvement Strategy NIHR Leeds Clinical Research Facility Patient and Public Involvement Strategy 2015-17 Leeds Teaching Hospitals NHS Trust Beckett Street, Leeds LS9 7TF http://www.leedsth.nhs.uk/research LCRF PPI Strategy

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1041-8 Program Prior Authorization/Notification Medication Humira (adalimumab) P&T Approval Date 1/2007, 6/2008, 4/2009, 6/2009,

More information

Hepatitis C Strategy. About us. What is hepatitis C?

Hepatitis C Strategy. About us. What is hepatitis C? Hepatitis C Strategy About us We support people to take control of their lives and make positive changes. For fifty years we have made a difference to people who want to change their relationship with

More information

Publication Plan 2017

Publication Plan 2017 Publication Plan 2017 A passion for turning high quality, independent research insights into actionable commercial intelligence. Why Spherix Global Insights? Our independent reports are designed, developed,

More information

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Please note that all information in this document is also disclosed in the overall report on Pfizer

More information

Magellan Rx. A smarter approach to pharmacy benefits management

Magellan Rx. A smarter approach to pharmacy benefits management Magellan Rx A smarter approach to pharmacy benefits management Presented by: Cheri Caruso, VP of Sales, Magellan Rx Management Bryce Canfield, VP, Client Development, GoodRx A unique vision of care We

More information

Membership of cirrhosis guideline Committee

Membership of cirrhosis guideline Committee Membership of cirrhosis guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on cirrhosis. The terms of reference and standing orders for the

More information

MRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh

MRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh Edinburgh All All Ireland Ireland North West Midlands MRC-CTSU - CTSU MRC MRC- - BSU ConDuCT MRC- - CTU MRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh www.methodologyhubs.mrc.ac.uk

More information

Assessment of Inflammatory Back Pain: New Concepts in Diagnosis

Assessment of Inflammatory Back Pain: New Concepts in Diagnosis Assessment of Inflammatory Back Pain: New Concepts in Diagnosis March 2 nd, 2018 Spine Therapy Network Interprofessional Synposium Sheraton Toronto Airport Hotel, Toronto, CANADA Laura Passalent PT, BScPT,

More information

British Society for Immunology. Corporate Membership Packages

British Society for Immunology. Corporate Membership Packages Corporate Membership Packages Become a corporate member and support the immunology community Activities that our corporate members support Our members come from 56 countries around the world. Immunology

More information

Certolizumab pegol (Cimzia) for the treatment of ankylosing spondylitis second or third line

Certolizumab pegol (Cimzia) for the treatment of ankylosing spondylitis second or third line Certolizumab pegol (Cimzia) for the treatment of ankylosing spondylitis second or third line August 2011 This technology summary is based on information available at the time of research and a limited

More information

Membership of Spondyloarthritis guideline Committee

Membership of Spondyloarthritis guideline Committee Membership of Committee The Committee will operate as an advisory Committee to NICE s Board developing clinical guideline on Spondyloarthritis The terms of reference and standing orders for the Committee

More information

In 2017, we are proud to have supported the following patient organisations:

In 2017, we are proud to have supported the following patient organisations: SERVIER LABORATORIES LTD YEAR ENDED 31 ST DECEMBER 2017 PATIENT ORGANISATIONS In 2017, we are proud to have supported the following patient organisations: Lymphoma Association The Lymphoma Association

More information

What prescribers need to know

What prescribers need to know HUMIRA Citrate-free presentations in an Electronic Medical Record (EMR) What prescribers need to know 2 / This is your guide to identifying HUMIRA Citrate-free presentations in your Electronic Medical

More information

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 Cristiana Oprea MD, Ph.D Associate Professor Carol Davila University of Medicine and Pharmacy Victor Babes Clinical Hospital for Infectious

More information

Who we are We are parents whose children s lives are touched by mental disorders. When we learned we weren t alone January 2000.and every day since

Who we are We are parents whose children s lives are touched by mental disorders. When we learned we weren t alone January 2000.and every day since www.forcesociety.com 604-878-3400 Who we are We are parents whose children s lives are touched by mental disorders When we learned we weren t alone January 2000.and every day since Why we formed a society

More information

The Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016

The Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016 The Prime Minister s Challenge on Dementia 2020 1 Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016 Costs and impact of dementia Estimated 676,000 people in England with

More information

Horizon Introduction. Alex Harris Medical Research Council

Horizon Introduction. Alex Harris Medical Research Council Horizon 2020 - Introduction Alex Harris Medical Research Council Agenda MRC and Horizon 2020 UK Success Rate (FP7 Health) What is Horizon 2020? The Horizon 2020 Health Challenge NCP support MRC and Horizon

More information

PEOS. Powering Patient Engagement in Hepatitis C treatment in Community Settings.

PEOS. Powering Patient Engagement in Hepatitis C treatment in Community Settings. PEOS Powering Patient Engagement in Hepatitis C treatment in Community Settings. INTRODUCTION Hepatitis C is a liver infection caused by the hepatitis C Virus which can result in inflammation and fibrosis

More information

Parkinson s information and support

Parkinson s information and support Parkinson s information and support A diagnosis of Parkinson s can turn your life upside down turn to us If you have Parkinson s, or you know someone who has, you ve probably got a lot of questions and

More information

Promoting the Voice and. Peta Halls Development Officer

Promoting the Voice and. Peta Halls Development Officer Promoting the Voice and Influence of Young People Peta Halls Development Officer National Youth Agency Our mission: enabling youth workers to transform lives Our focus: NYA helps youth workers to transform

More information

Bristol-Myers Squibb (UK & Ireland) Publication of Data on Patient Advocacy Groups - for the period 01 January to 31 December 2017

Bristol-Myers Squibb (UK & Ireland) Publication of Data on Patient Advocacy Groups - for the period 01 January to 31 December 2017 Bristol-Myers Squibb ( & Ireland) Publication of Data on Patient Advocacy Groups - for the period 01 January to 31 December 2017 Interaction Country Disease Area Patient Advocacy Group Name Contracted

More information

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2017

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2017 Pfizer Healthcare Ireland Patient Association Funding Disclosure 2017 Pfizer has implemented a standard approach for full transparency of grants and donations to patient organisations. With this commitment,

More information

Depression is a significant but often neglected effect of arthritis.

Depression is a significant but often neglected effect of arthritis. Arthritis Hurts The emotional impact of arthritis pain Executive Summary Depression is a significant but often neglected effect of arthritis. Three in five (68%) people with arthritis who responded to

More information

Warren Fahey President November 2017

Warren Fahey President November 2017 2016-2017 HNSW SERVICES & ANNUAL REPORT WELCOME BY WARREN AND STUART Welcome to our Hepatitis NSW Services and Annual Report 2016-17. The opportunities and optimism generated by the availability of the

More information

HCV ACTION EAST OF ENGLAND HEPATITIS C GOOD PRACTICE ROADSHOW, 9TH MAY 2017 SUMMARY REPORT

HCV ACTION EAST OF ENGLAND HEPATITIS C GOOD PRACTICE ROADSHOW, 9TH MAY 2017 SUMMARY REPORT HCV ACTION EAST OF ENGLAND HEPATITIS C GOOD PRACTICE ROADSHOW, 9TH MAY 2017 SUMMARY REPORT Introduction With hepatitis C representing a significant public health concern in the Cambridge and East of England

More information

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report About HCV Action HCV Action is a network, co-ordinated by The Hepatitis C Trust, that brings together health professionals

More information

Recruitment Information Pack. Participation and Influence Manager

Recruitment Information Pack. Participation and Influence Manager Recruitment Information Pack Participation and Influence Manager Introduction Job Title Participation & Influence Manager (temporary) Team Policy & Campaigns Immediate start preferred Fixed term contract

More information

Pentavalent Market. UNICEF/UN074464/Lister. UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation

Pentavalent Market. UNICEF/UN074464/Lister. UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation Pentavalent Market UNICEF/UN074464/Lister UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation UNICEF/UN074371/Dragaj OUTLINE Historical demand and market overview Healthy Market Current Tender 2017-2019

More information

About Arthritis

About Arthritis About Arthritis www.arthritis.org.nz Did you know? Arthritis affects more than 530,000 New Zealanders. In fact, it is the greatest cause of disability in this country. Arthritis literally means inflammation

More information

infliximab, 100mg, powder for concentrate for solution for infusion (Inflectra ) SMC No. (1007/14) Hospira UK Ltd.

infliximab, 100mg, powder for concentrate for solution for infusion (Inflectra ) SMC No. (1007/14) Hospira UK Ltd. infliximab, 100mg, powder for concentrate for solution for infusion (Inflectra ) SMC No. (1007/14) Hospira UK Ltd. 07 November 2014 (Issued 06 March 2015) The Scottish Medicines Consortium (SMC) has completed

More information

Relationships with Healthcare Organisations, Patient Organisations and Healthcare Professionals

Relationships with Healthcare Organisations, Patient Organisations and Healthcare Professionals Relationships with Healthcare s, Patient s and Healthcare Professionals Healthcare and Patient s CSL Behring makes available a number grants to Healthcare and Patient s. Grants are made in accordance with

More information

adalimumab, 40mg/0.8mL, solution for injection (Humira ) SMC No. (858/13) AbbVie Ltd (previously part of Abbott)

adalimumab, 40mg/0.8mL, solution for injection (Humira ) SMC No. (858/13) AbbVie Ltd (previously part of Abbott) adalimumab, 40mg/0.8mL, solution for injection (Humira ) SMC No. (858/13) AbbVie Ltd (previously part of Abbott) 08 March 2013 The Scottish Medicines Consortium (SMC) has completed its assessment of the

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review Review of TA143 Adalimumab, etanercept and infliximab for ankylosing spondylitis

More information

Professor Karl Claxton, Centre for Health Economics, University of York

Professor Karl Claxton, Centre for Health Economics, University of York Welcome to the InstEAD Annual Lecture 2014 Professor Karl Claxton, Centre for Health Economics, University of York Health (and ethics) Needs Economics: Which Health Technologies, at What Price and for

More information

Uveitis Update DISCLOSURE STATEMENT. Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO

Uveitis Update DISCLOSURE STATEMENT. Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO Uveitis Update Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO DISCLOSURE STATEMENT We have no direct financial or proprietary interest in any companies, products or services mentioned in this presentation.

More information

Patient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility

Patient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility Patient and Public Involvement, Engagement and Participation Strategy 2017-2022 NIHR Newcastle Clinical Research Facility Context The NIHR Newcastle Clinical Research Facility (CRF) delivers high quality,

More information

Not Myself Today Europe Project Development

Not Myself Today Europe Project Development Not Myself Today Europe Project Development Depression causes lost work productivity, long-term sick leave and early retirement 1 in 10 working people have taken time off work due to depression 350 million

More information

Humira. (adalimumab) Drug Update Slideshow NEW INDICATION

Humira. (adalimumab) Drug Update Slideshow NEW INDICATION Humira (adalimumab) NEW INDICATION Drug Update Slideshow Introduction Brand name: Humira Generic name: Adalimumab Pharmacological class: Tumor necrosis factor (TNF) blocker Strength and Formulation: 10mg/0.2mL,

More information

Young Planners Conference November, Manchester

Young Planners Conference November, Manchester Young Planners Conference 2017 3-4 November, Manchester Sponsorship Opportunities #YPConf2017 Sponsoring the Young Planners Conference was a great opportunity for us to meet and network with numerous planning

More information

European Patients Academy on Therapeutic Innovation

European Patients Academy on Therapeutic Innovation European Patients Academy on Therapeutic Innovation http://www.patientsacademy.eu info@patientsacademy.eu The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under

More information

Dorset Cancer Alliance:

Dorset Cancer Alliance: Dorset Cancer Alliance: - Structure and Functions - SSG specification Where are we without a Network? Wessex Strategic Cancer Network Individual Trust Cancer Services Dorset CCG Specialised Commissioning

More information

We promise to involve you

We promise to involve you We promise to involve you Autistica is the UK s autism research charity. We exist to give every autistic person and their family the chance of a long, healthy, happy life through research. To achieve our

More information

UK Anti-Doping (UKAD) and British Association of Sport and Exercise Sciences (BASES) Partnership Agreement Liam Jefferson January 2018

UK Anti-Doping (UKAD) and British Association of Sport and Exercise Sciences (BASES) Partnership Agreement Liam Jefferson January 2018 UK Anti-Doping () and British Association of Sport and Exercise Sciences () Partnership Agreement Liam Jefferson January Official Overview Background UK Anti-Doping () has a clear objective to prevent

More information

Why is this important for you? Types of arthritis. Information for the public Published: 28 February 2017 nice.org.uk

Why is this important for you? Types of arthritis. Information for the public Published: 28 February 2017 nice.org.uk Spondyloarthritis in over 16s: diagnosis and management Information for the public Published: 28 February 2017 nice.org.uk Spondyloarthritis: the care you should expect This information explains the care

More information

VALUE TO A SPONSOR PARTNER OR DONOR. Dementia Alliance International

VALUE TO A SPONSOR PARTNER OR DONOR. Dementia Alliance International VALUE TO A SPONSOR PARTNER OR DONOR Dementia Alliance International ABOUT DEMENTIA ALLIANCE INTERNATIONAL (DAI) Dementia Alliance International (DAI) is a registered non-profit organisation and a US Corporation

More information

Watch and Wait. A Guide for Patients

Watch and Wait. A Guide for Patients Watch and Wait A Guide for Patients Introduction Some blood cancers progress rapidly and therefore require treatment straightaway. Others progress slowly and the patient may not experience any symptoms

More information

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2013

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2013 Pfizer Healthcare Ireland Patient Association Funding Disclosure 2013 Pfizer has implemented a new standard approach for full transparency of grants to patient organisations. With this new commitment,

More information

Local Action Plan WALES

Local Action Plan WALES 1 Local Action Plan 2017-2019 WALES Background As of 1 st January 2017 there were 230 people known to the Association with MND, 6 MND Association branches and, 14 regularly active Multi- Disciplinary teams

More information

Drug Name (specify drug) Quantity Frequency Strength

Drug Name (specify drug) Quantity Frequency Strength Prior Authorization Form GEHA FEDERAL - STANDARD OPTION Autoimmune Conditions (FA-PA) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign

More information

Horizon Scanning Technology Summary. Adalimumab (Humira) for juvenile idiopathic arthritis. National Horizon Scanning Centre.

Horizon Scanning Technology Summary. Adalimumab (Humira) for juvenile idiopathic arthritis. National Horizon Scanning Centre. Horizon Scanning Technology Summary National Horizon Scanning Centre Adalimumab (Humira) for juvenile idiopathic arthritis June 2007 This technology summary is based on information available at the time

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: McCoy MS, Carniol M, Chockley K, Urwin JW, Emanuel EJ, Schmidt

More information

Public Engagement and Public and Patient Involvement. NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit

Public Engagement and Public and Patient Involvement. NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit Public Engagement and Public and Patient Involvement NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit Our vision Patients, their carers and the wider public are a fundamental and

More information

Improving efficiency in health. Hepatitis C virus session

Improving efficiency in health. Hepatitis C virus session Improving efficiency in health Hepatitis C virus session Aims of this session Optima is a tool to assist in reducing the burden of diseases by optimizing resource allocation. This session will discuss:

More information

axial spondyloarthritis including ankylosing spondylitis

axial spondyloarthritis including ankylosing spondylitis 1 What is spondyloarthritis? Spondyloarthritis is a general term that describes a number of types of inflammatory arthritis which share many articular and extra-articular features. Conditions which fall

More information

2. Has the patient had a response to treatment? Y N. 3. Does the patient have a diagnosis of rheumatoid arthritis (RA)? Y N

2. Has the patient had a response to treatment? Y N. 3. Does the patient have a diagnosis of rheumatoid arthritis (RA)? Y N 12/21/2016 Prior Authorization Aetna Better Health of West Virginia Humira (WV88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and

More information

Joining BILD offers you real benefits and supports us in our work

Joining BILD offers you real benefits and supports us in our work BILD Membership Joining BILD offers you real benefits and supports us in our work Find out more at www.bild.org.uk/membership BILD is one of the leading learning disabilities organisations in the UK. Founded

More information

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #:

HEALTH SCREENING QUESTIONNAIRE. Work-up. Donor ID EdgeCell #: HEALTH SCREENING QUESTIONNAIRE Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca CT

More information

Blackpool, Wyre and Fylde Council for Voluntary Service

Blackpool, Wyre and Fylde Council for Voluntary Service Blackpool, Wyre and Fylde Council for Voluntary Service Lifestyle Issues (157) Drug/Alcohol 14 VCFS Statistics 2013 Health & Social Care (697) Child Care 21 Society and Environment (374) Economic/ Community

More information

Priority Health Medicare prior authorization form Fax completed form to: toll free, or

Priority Health Medicare prior authorization form Fax completed form to: toll free, or Priority Health Medicare prior authorization form Fax completed form to: 877.974.4411 toll free, or 616.942.8206 This form applies to: Medicare Part B Medicare Part D This request is: Expedited request

More information

The Leeds Teaching Hospitals NHS Trust. Positive Patient and Public Involvement (PPI) in Research at Leeds

The Leeds Teaching Hospitals NHS Trust. Positive Patient and Public Involvement (PPI) in Research at Leeds n The Leeds Teaching Hospitals NHS Trust Positive Patient and Public Involvement (PPI) in Research at Leeds Acknowledgements We would like to thank the following PPI members for their contributions in

More information

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS Baker D 1,2, McMurchie M 1, Rodgers C 1, Farr V 1, Williams M 1 1 East Sydney Doctors, 2 Australasian Society for HIV Medicine 1 Disclosures Advisory

More information

Supporting Prisoners Families. A Multi-Agency Approach

Supporting Prisoners Families. A Multi-Agency Approach Supporting Prisoners Families A Multi-Agency Approach Introductions Tracey Holder Senior Parenting Practitioner Chris Kavanagh Parental Involvement Worker Good practice in Brighton & Hove Supporting Families

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Measurement of Serum Antibodies to Infliximab, Adalimumab and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: measurement_of_serum_antibodies_to_infliximab_and_adalimumab

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA96; Adefovir dipivoxil and peginterferon alfa-2a for

More information

Primary Results Citation 2

Primary Results Citation 2 Table S1. Adalimumab clinical trials 1 ClinicalTrials.gov Rheumatoid Arthritis 3 NCT00195663 Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study. A multicenter, randomized, double-blind clinical

More information

Exhibitor Opportunities

Exhibitor Opportunities 7 th July 2018 Glasgow University, Wolfson Medical Building, Yudowitz Room and Atrium Exhibitor Opportunities Meet the LDN Community ABOUT THE EVENT Low-Dose Naltrexone (LDN) is quickly becoming established

More information

Services and Support Information Leaflet

Services and Support Information Leaflet Services and Support Information Leaflet Services Free HIV and STI Testing Free HIV and STI testing takes place in HIV Ireland on the second and fourth Wednesdays of every month ( exclusive of holidays

More information

HEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #:

HEALTH SCREENING QUESTIONNAIRE CT Work-up. Donor ID EdgeCell #: HEALTH SCREENING QUESTIONNAIRE CT Work-up Héma-Québec Registre des Donneurs de Cellules Souches 4045 Côte-vertu, St-Laurent, QC, Canada, H4R 2W7 Tél : + 514-832-1031 Fax : + 514-832-0266 www.hema-quebec.qc.ca

More information

STRATEGIC APPROACH & WORKPLAN 2007

STRATEGIC APPROACH & WORKPLAN 2007 Rare Diseases Europe STRATEGIC APPROACH 2007-2009 & WORKPLAN 2007 Paris, March 2007 www.eurordis.org Contents Our strategic approach 2007 2009 o Eurordis in 2010 o Strategic orientations o Priorities 2007-2009

More information

Barbra Bohannan Head of Operations and Strategic Communications

Barbra Bohannan Head of Operations and Strategic Communications Barbra Bohannan Head of Operations and Strategic Communications Psoriasis - a serious, and common, disease Psoriasis has a major impact on healthrelated quality of life that is comparable to other major

More information

A Patient Information Guide My Guide to HCV treatment and care. Helpful information for patients who have been prescribed MAVIRET

A Patient Information Guide My Guide to HCV treatment and care. Helpful information for patients who have been prescribed MAVIRET A Patient Information Guide My Guide to HCV treatment and care Helpful information for patients who have been prescribed MAVIRET The information in this booklet does not replace the Patient Information

More information

STRATEGIC PLAN 2014 to 2017

STRATEGIC PLAN 2014 to 2017 STRATEGIC PLAN 2014 to 2017 September 2014 1 P a g e KHNZ s STRATEGIC PLAN Contents Page 1. Introduction to the Strategic Plan 3 2. About Kidney Health New Zealand 4 3. The Challenges 6 4. Strategic Context

More information

Denver, August 29, 2010

Denver, August 29, 2010 Denver, August 29, 2010 You Can Make a Difference About Psoriasis Psoriasis is a chronic, autoimmune disease that appears on the skin. It occurs when the immune system sends out faulty signals that speed

More information

Understanding Rheumatoid Arthritis

Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis Contents Introduction...3 What is rheumatoid arthritis?...4 Symptoms of rheumatoid arthritis... 5 What causes rheumatoid arthritis?... 10 The role of genes and family

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review Review of TA159; Spinal cord stimulation for chronic pain of neuropathic or ischaemic

More information

Case Example: Exposure Response to Support Extrapolation of Efficacy in Pediatric Ulcerative Colitis

Case Example: Exposure Response to Support Extrapolation of Efficacy in Pediatric Ulcerative Colitis Case Example: Exposure Response to Support Extrapolation of Efficacy in Pediatric Ulcerative Colitis Kerry Jo Lee, MD Medical Officer Division of Gastroenterology and Inborn Error Products Office of New

More information

First Name. Specialty: Fax. First Name DOB: Duration:

First Name. Specialty: Fax. First Name DOB: Duration: Prescriber Information Last ame: First ame DEA/PI: Specialty: Phone - - Fax - - Member Information Last ame: First ame Member ID umber DOB: - - Medication Information: Drug ame and Strength: Diagnosis:

More information

OUT NORTH WEST ROLE DESCRIPTION

OUT NORTH WEST ROLE DESCRIPTION OUT NORTH WEST ROLE DESCRIPTION Job Title: Out North West Youth Development Officer Responsible to: Health and Wellbeing Services Manager (The Rainbow Project) and Youth Development Manager (Cara-Friend)

More information

Bexley Voice Annual General Meeting. 19 th September 2018

Bexley Voice Annual General Meeting. 19 th September 2018 Bexley Voice Annual General Meeting 19 th September 2018 Welcome to our 9 th Bexley Voice Annual General Meeting. Overview of our core activity 2017 ~ 2018 Plans for the future Opportunities to get involved

More information

HOSPITAL In The HOME SOCIETY AUSTRALASIA STATEGIC PLAN

HOSPITAL In The HOME SOCIETY AUSTRALASIA STATEGIC PLAN HOSPITAL In The HOME SOCIETY AUSTRALASIA STATEGIC PLAN 2015-2018 Mission; The Hospital in the Home (HITH) Society of Australasia is the peak independent industry organisation developed by leaders in their

More information

The National Bereavement Care Pathway

The National Bereavement Care Pathway The National Bereavement Care Pathway Marc Harder SANDS Sponsored by Marc Harder, Project Lead Presentation to ICCM Convention September 2017 The doctor and midwife had tears in their eyes. The doctor

More information

ASSOCIATION OF FUNDRAISING PROFESSIONALS MASSACHUSETTS CHAPTER SPONSORSHIP OPPORTUNITIES

ASSOCIATION OF FUNDRAISING PROFESSIONALS MASSACHUSETTS CHAPTER SPONSORSHIP OPPORTUNITIES ASSOCIATION OF FUNDRAISING PROFESSIONALS MASSACHUSETTS CHAPTER SPONSORSHIP OPPORTUNITIES 2017-18 Why become a sponsor of AFP MA Chapter? Increase your organization s recognition and build relationships

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,

More information

CROSS-PARTY GROUP REGISTRATION FORM

CROSS-PARTY GROUP REGISTRATION FORM CROSS-PARTY GROUP REGISTRATION FORM NAME OF CROSS-PARTY GROUP Cross-Party Group on Cancer PURPOSE OF THE GROUP AND PROPOSED DISCUSSION TOPICS 1. Please state the purpose of the Group. 2. Please also provide

More information